GSK620
BD2 domain selective BET inhibitor oral efficacy in 3 inflammation models from SBDD of a BD2-selective HTS hit Science, Mar. 19, 2020 GlaxoSmithKline, Stevenage, UK
Molecules of the Month - March 2020
Molecules of the Month
- CC-92480
- “PROTAC 6”
- GSK620
- Merck hArg1 inhibitor
- Merck IDO1 inhibitor
- Constellation EZH2 inhibitor
- Arcus CD73 inhibitor
- MK-6884
- sulfopin
- M3814
- remibrutinib